FDA to streamline some cancer therapy reviews with Canada, Australia

FDA to streamline some cancer therapy reviews with Canada, Australia

STAT Plus: FDA and counterparts in Canada, Australia to collaborate on cancer therapy reviews

By ANDREW JOSEPH

ANDREW HARNIK/AP

Under the new effort, companies can file their applications to three regulatory agencies, which will review them concurrently and collaboratively.

READ MORE